Antiatherogenic properties of calcium channel blockers
- 25 March 1988
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 84 (3), 102-108
- https://doi.org/10.1016/0002-9343(88)90197-0
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Verapamil inhibits serotonin uptake of endothelial cells in culture by a mechanism unrelated to Ca2+ channel blockadeJournal of Cellular Physiology, 1987
- Antiatherogenic properties of calcium antagonistsThe American Journal of Cardiology, 1987
- The mechanism of action of calcium antagonists relative to their clinical applications.British Journal of Clinical Pharmacology, 1986
- Calcium antagonists and their mode of action: an historical overview.British Journal of Clinical Pharmacology, 1986
- Diphenylalkylamine calcium antagonists interact with α-adrenoceptor binding sites in aortic membranesEuropean Journal of Pharmacology, 1985
- Effects of dihydropyridine calcium channel blocking drugs on rat brain muscarinic and α-adrenergic receptorsBiochemical Pharmacology, 1985
- Adenosine uptake sites in dog heart and brain; interaction with calcium antagonistsLife Sciences, 1984
- Stimulation of Na+,K+-ATPase of isolated smooth muscle membranes by the Ca2+ channel inhibitors, nimodipine and nitrendipineBiochemical Pharmacology, 1984
- Calcium antagonistic drugs differ in ability to block the slow Na+ channels of young embryonic chick heartsEuropean Journal of Pharmacology, 1983
- Calcium-Channel-Blocking AgentsNew England Journal of Medicine, 1983